Cardiac Valve Diseases and Treatments Open access Peer reviewed

Interventional treatment options for elderly patients with mitral regurgitation

Dominik Felbel, Wolfgang Rottbauer, Mirjam Keßler

Future Cardiology | Aug 17, 2026

Scollr summary

What this paper is about

Current evidence on safety, functional outcomes, QoL, survival, emerging replacement strategies, and conservative management in elderly patients with MR is summarized.

Full abstract

Read the full abstract

The prevalence of mitral regurgitation (MR), particularly degenerative MR (DMR), rises with advancing age. Elderly patients frequently carry increased surgical risk due to frailty and comorbidities, leading to a prohibitive risk of conventional surgery. For such patients, mitral transcatheter edge-to-edge repair (M-TEER) provides a minimally invasive alternative to surgical repair. Data from large registries, including TRAMI (Transcatheter Mitral Valve Interventions) and EXPAND (The MitraClip™ EXPAND Study of the Next Generation of MitraClip™ Devices), demonstrate high procedural success, low 30-day mortality (2-3%) and stroke rates (<1%), and durable improvements in functional status and quality of life (QoL) in elderly cohorts. Although definitions of "elderly" vary between studies (≥75, ≥80, or ≥85 years) and benefits are consistently observed, elderly was defined ≥75 years within this review. For selected patients unsuitable for M-TEER, transcatheter mitral valve replacement (TMVR) can achieve effective MR elimination, with reported 1-year mortality ranging from 7% to 17% in early transfemoral, transseptal experiences and up to 29% after transapical TMVR. This review summarizes current evidence on safety, functional outcomes, QoL, survival, emerging replacement strategies, and conservative management in elderly patients with MR.

Direct answer

What can I do from this paper page?

Use this page to scan "Interventional treatment options for elderly patients with mitral regurgitation" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Cardiac Valve Diseases and Treatments research, save the paper, or map adjacent work.

Authors

Researchers on this paper

Dominik Felbel

first | Universität Ulm | ORCID 0000-0003-0649-7364

Wolfgang Rottbauer

middle | Universität Ulm | ORCID 0000-0003-4725-6217

Mirjam Keßler

last | Universität Ulm | ORCID 0000-0001-6423-0508

Research areas

Follow related topics

Citation

BibTeX

@article{Felbel2026Interventional,
  title = {Interventional treatment options for elderly patients with mitral regurgitation},
  author = {Dominik Felbel and Wolfgang Rottbauer and Mirjam Keßler},
  journal = {Future Cardiology},
  year = {2026},
  doi = {10.1080/14796678.2026.2718644},
  url = {https://doi.org/10.1080/14796678.2026.2718644}
}

FAQ

Using this paper in a discovery workflow

How do I find related work for this paper?

Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.

How can I keep up with new Cardiac Valve Diseases and Treatments research papers?

Follow Cardiac Valve Diseases and Treatments research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.

Can I cite this paper from this page?

This page includes a static BibTeX block for Interventional treatment options for elderly patients with mitral regurgitation. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.

Follow this research in Scollr

Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.

Get the app